Stockscreener 앱 받기
42.60
0.81%
-0.35
시간 외 거래:
42.60
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen stock holds steady after Q2 2026 beat and guidance reaffirmation - AD HOC NEWS
Handelsbanken Fonder AB Takes $2.91 Million Position in Qiagen N.V. $QGEN - MarketBeat
QIAGEN NV Revenue Breakdown – TRADEGATE:QIA - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen stock holds above $43 as Q2 2026 beat backs cautious valuation - ad-hoc-news.de
Qiagen (QGEN) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Qiagen stock holds above $43 as Q2 2026 earnings beat outlook - AD HOC NEWS
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip? - Yahoo Finance
Qiagen stock steadies after Q2 2026 guidance is reaffirmed - AD HOC NEWS
Qiagen stock gains after Q2 beat and fresh FDA clearance - AD HOC NEWS
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Qiagen N.V. : DZ Bank reiterates its Buy rating - marketscreener.com
Goldman Sachs Discloses 2.63% Voting Interest in Qiagen via AFM Filing - The Globe and Mail
Qiagen N.V. (QGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Qiagen Sees Unusually High Options Volume (NYSE:QGEN) - MarketBeat
Goldman Sachs lifts Qiagen voting rights to 2.63% via instruments - Bitget
Qiagen NV (QGEN) Shares Surge 3.7% -- What GF Score of 76 Tells Investors - GuruFocus
New QIAGEN Test Detects 20 Pathogen Targets in About an Hour - Stock Titan
QGEN Maintained by Citigroup -- Price Target Raised to $45.00 - GuruFocus
QIAGEN Wins FDA Clearance for a One-Hour Bloodstream Infection Test, With Montgomery County Ties Behind It - BioBuzz
Understanding Qiagen (QGEN) Reliance on International Revenue - Yahoo Finance
Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential With An 8.24% Upside - DirectorsTalk Interviews
Qiagen N.V. : Deutsche Bank remains its Buy rating - marketscreener.com
Qiagen NV (QGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company - marketbeat.com
Qiagen Q2 Earnings Call Highlights - MarketBeat
QIAGEN Beats Q2 2026 Guidance, Reaffirms Full-Year Outlook Amid Mixed Demand - The Globe and Mail
William Blair Maintains Qiagen NV(QGEN.US) With Hold Rating - 富途牛牛
How Investors Are Reacting To Qiagen (QGEN) Capital Structure Overhaul And US$200 Million Repayment Plan - Sahm
Qiagen NV (QGEN) Stock News Today - TradingKey
Qiagen N.V. Stock 12‑Month Price Target Raised to $44.52, Implies 7% Upside - TradingView
QGEN Maintained by Barclays -- Price Target Raised to $40 - GuruFocus
Qiagen NV (QIA.SG) stock price, news, quote and history - Yahoo Finance UK
QGEN Maintained by JP Morgan -- Price Target Raised to $50 - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $50.00 - MarketBeat
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09 - 富途牛牛
Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Qiagen N.V. (QGEN) Stock Forecasts - Yahoo Finance
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen N.V. (NYSE: QGEN) Q2 2026 profit, $496.7M synthetic buyback and cash flows - stocktitan.net
QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets - Stock Titan
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - marketbeat.com
Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN - MarketBeat
Bank of America Corp DE Sells 418,992 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen NV (QGEN) (Q2 2026) Earnings Call Highlights: Beats Guida - GuruFocus
Qiagen (NYSE:QGEN) Updates Q3 2026 Earnings Guidance - MarketBeat
Qiagen N.V. : Jefferies reiterates its Buy rating - marketscreener.com
QIAGEN Q2 2026 slides: flat growth masks strong pillar performance - Investing.com
Qiagen: Q2 ahead of expectations; like peers, there's no change to guidance - marketscreener.com
Qiagen NV (0RLT) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Qiagen N.V. 2026 Q2ResultsEarnings Call Presentation (NYSE:QGEN) 2026-08-06 - Seeking Alpha
Q2 2026 Qiagen NV Earnings Call Transcript - GuruFocus
QIAGEN NV : Buy rating from Jefferies - marketscreener.com
QIAGEN NV : Deutsche Bank maintains a Buy rating - marketscreener.com
Qiagen N.V. Q2 2026 Earnings Call Summary - finance.yahoo.com
Qiagen NV (QGEN) (Q2 2026) Earnings Call Highlights: Beats Guidance, Reaffirms H2 Growth ... By GuruFocus - Investing.com Canada
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook - biospace.com
QIAGEN N.V. reports results for the quarter ended June 30Earnings Summary - TradingView
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Qiagen (QGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Qiagen: Q2 Earnings Snapshot - marketscreener.com
Qiagen Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Qiagen reports flat Q2 sales, reaffirms 2026 outlook - Investing.com
Qiagen reports flat Q2 sales, reaffirms 2026 outlook By Investing.com - Investing.com Nigeria
AFM Discloses T. Rowe Price’s 4.97% Stake in Qiagen - The Globe and Mail
Earnings Flash (QGEN) QIAGEN N.V. Reports Q2 Revenue $535.0M, vs. FactSet Est of $527.5M - marketscreener.com
Earnings Flash (QGEN) QIAGEN N.V. Posts Q2 Adjusted EPS $0.62 per Share, vs. FactSet Est of $0.60 - marketscreener.com
1.64%
0.11%
자본화:
|
볼륨(24시간):